Status:
COMPLETED
Effectiveness of Care in Certified Cancer Centres in Germany
Lead Sponsor:
Technische Universität Dresden
Collaborating Sponsors:
Tumorzentrum Regensburg, Institut für Qualitätssicherung und Versorgungsforschung, Universität Regensburg
Arbeitsgemeinschaft Deutscher Tumorzenten e.V., ADT
Conditions:
Colorectal Cancer
Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Assessment of the effectiveness of care in certified cancer centres for eight cancer entities via a retrospective cohort study based on secondary data from statutory health insurance funds and populat...
Detailed Description
Cancer constitutes the second most frequent cause of death in Germany. To maintain a high quality of treatment, the national cancer plan aims at a unified certification of cancer centres. The project...
Eligibility Criteria
Inclusion
- first hospitalization due to diagnosis of colorectal cancer, pancreatic cancer, breast cancer, gynecologic tumors, lung cancer, prostate cancer, head and neck tumors, or neuro-oncological tumors 2009-2017 \[WIdO\]
- hospitalization due to primary diagnosis of colorectal cancer, pancreatic cancer, breast cancer, gynecologic tumors, lung cancer, prostate cancer, head and neck tumors, or neuro-oncological tumors 2006-2017 \[CCR\]
Exclusion
- prevalent diagnosis of colorectal cancer, pancreatic cancer, breast cancer, gynecologic tumors, lung cancer, prostate cancer, head and neck tumors, or neuro-oncological tumors 2006-2017
- exception: outpatient cancer diagnosis up to 12 months prior to first hospitalization is not regarded as prevalent
Key Trial Info
Start Date :
May 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
670000 Patients enrolled
Trial Details
Trial ID
NCT04334239
Start Date
May 1 2017
End Date
August 31 2021
Last Update
August 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Technische Universität Dresden
Dresden, Saxony, Germany, 01307